Founded in 1986 by the Chan family, Morningside is a technology and life science venture investment firm. With offices in Boston, Shanghai and London, the firm invests globally. The group is managed by investment professionals who are entrepreneurial, have deep industry knowledge and are effective in the local environment in which they operate. In addition to its investment activities, Morningside Ventures is strongly committed to social responsibility.
18
Total Investments
18
Portfolio Companies
-
Exits
4
Industries
General Information
Industries
Biotechnology, Finance +2
Funding Stage
Seed +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Morningside Ventures
Recent Investments (18)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Sep 2023 | |
| Series A | •••••• | May 2023 | |
| Venture Round | •••••• | Dec 2022 | |
| Seed Round | •••••• | Sep 2022 | |
| Seed Round | •••••• | Jul 2022 | |
•••• ••••
|
Seed Round | •••••• | May 2022 |
|
•••• ••••
|
Series C | •••••• | May 2022 |
|
•••• ••••
|
Series C | •••••• | Mar 2022 |
|
•••• ••••
|
Series B | •••••• | Jan 2022 |
|
•••• ••••
|
Series C | •••••• | Nov 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
